Sign in to confirm you’re not a bot
This helps protect our community. Learn more
These chapters are auto-generated

Introduction

0:00

Agenda

1:08

Basic immunological principles

4:40

Vaccines

10:40

Challenges and advantages

19:22

Game changer

26:21

COVID19 pandemic

27:01

Production of antigens

28:27

Large amounts of antigens

29:36

Flexibility

31:20

Regulatory innovation

34:22

In principle

35:34

Question time

36:49

Adjuvants

37:55

Injectable or pill

40:11

Do the science

41:12

C1 vaccine production

44:15

Limitations of current vaccines

46:21

Spike protein conserved among variants

48:21

Can C1 platform be used for manufacturing antibodies

52:49

Multivalent vaccine

54:23

Delay in testing

57:44
Dyadic KOL Fireside Chat May 2021
5Likes
436Views
2021May 4
“The Potential of The Transformative Dyadic C1 Protein Production Technology in Helping Meet Global Health Challenges” featuring a discussion moderated by Dr. David Bramhill with Key Opinion Leaders.

Follow along using the transcript.